Attached files
| file | filename |
|---|---|
| S-1 - S-1 - Aclaris Therapeutics, Inc. | a2225650zs-1.htm |
| EX-3.4 - EX-3.4 - Aclaris Therapeutics, Inc. | a2225650zex-3_4.htm |
| EX-3.1 - EX-3.1 - Aclaris Therapeutics, Inc. | a2225650zex-3_1.htm |
| EX-10.4 - EX-10.4 - Aclaris Therapeutics, Inc. | a2225650zex-10_4.htm |
| EX-10.5 - EX-10.5 - Aclaris Therapeutics, Inc. | a2225650zex-10_5.htm |
| EX-21.1 - EX-21.1 - Aclaris Therapeutics, Inc. | a2225650zex-21_1.htm |
| EX-10.8 - EX-10.8 - Aclaris Therapeutics, Inc. | a2225650zex-10_8.htm |
| EX-10.12 - EX-10.12 - Aclaris Therapeutics, Inc. | a2225650zex-10_12.htm |
| EX-10.2 - EX-10.2 - Aclaris Therapeutics, Inc. | a2225650zex-10_2.htm |
| EX-10.7 - EX-10.7 - Aclaris Therapeutics, Inc. | a2225650zex-10_7.htm |
| EX-10.6 - EX-10.6 - Aclaris Therapeutics, Inc. | a2225650zex-10_6.htm |
| EX-10.3 - EX-10.3 - Aclaris Therapeutics, Inc. | a2225650zex-10_3.htm |
| EX-10.1 - EX-10.1 - Aclaris Therapeutics, Inc. | a2225650zex-10_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of Aclaris Therapeutics, Inc. of our report dated April 2, 2015 relating to the financial statements of Aclaris Therapeutics, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Philadelphia,
Pennsylvania
August 17, 2015
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM